CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
 
About CLDF | Mission Statement
The foundation's goal is to provide health professionals with the most current education and information on CLD.
 
Educational programs are designed so physicians, nurses, nurse practitioners, physician assistants, and pharmacists have information about the latest medical developments and their implications for patient management. Information is drawn from academia, medical societies, government health agencies, and the pharmaceutical industry, and is integrated into balanced, up-to-date educational programs and materials for health professionals.
 
The Chronic Liver Disease Foundation is a nonprofit 501(c)(3) educational organization dedicated to increasing awareness of the effect of chronic liver disease (CLD) in the United States. All grants awarded to CLDF are restricted to support our programs and are not used for salaries and general administrative expenses of the Chronic Liver Disease Foundation.
 
Overview
The Chronic Liver Disease Foundation provides education to the medical community concerning a disease that affects an estimated 40 million people in the United States.
 
The most common types of CLD in the United States include nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, chronic hepatitis C, alcoholic liver disease, chronic hepatitis B, and hemochromatosis.
 
For all age groups, CLD was the 12th leading cause of death in the year 2000, accounting for more than 25,000 deaths. In the 45 to 54 age group, CLD and cirrhosis were the 4th leading cause of death in males, and the 6th leading cause of death in females.
 
More than 17,000 patients are currently on the liver transplant waiting list, yet just over 5000 patients receive liver transplants each year.
 
New therapies continue to evolve in the treatment of CLD. New molecular testing techniques aid in the detection and therapeutic monitoring of liver disease. Recombinant vaccines have been developed for 2 common types of hepatitis. And, in those cases where liver disease has progressed to a point where treatment is no longer effective, liver transplant has become a more viable option, in most instances, than it was just a decade ago.
 
The Chronic Liver Disease Foundation is committed to providing healthcare professionals with the latest developments in understanding liver disease. Educational opportunities are offered in a variety of formats including an interactive Web site, live meetings, teleconferences, print pieces, audiocassettes, and CD-ROMS.
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.